Dayton Misfeldt, Director, 10% Owner at SUNESIS PHARMACEUTICALS INC (SNSS), bought 24,011,350 shares at $0.28 ($6.7M) on 2010-06-30, disclosed to the SEC on 2010-07-01.
Open-market purchase of $6.7M SNSS by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 186,900 | $0 | 0.0% |
| 2 | $0.28 | 445,516 | $125K | 1.9% |
| 3 | $0.28 | 23,378,934 | $6.5M | 98.1% |
| Total | $0.28 avg | 24,011,350 | $6.7M | 100% |
| Filing → |
| SNSS | SELL | 2015-12-21 | $2.2M | — | Filing → |
| SNSS | SELL | 2014-08-29 | $2.4M | — | Filing → |
| SNSS | SELL | 2014-08-12 | $4.9M | — | Filing → |